Interview: Charles River taps China's emergence as a base for innovation
18 November 2009
Ian Haydock
Please Login to read the full article.
18 November 2009
Ian Haydock
ian.haydock@informa.com
The increase in drug research being carried out by multinationals in China is creating growing demand for supporting contract services to international standards.
Charles River Laboratories (CRL) first spotted what it considered to be this attractive opportunity several years ago, and decided to...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Lonza and Fosun Chinese biopharm generic JV will "protect customer IP"
- China must clean up act before it can join fully in global pharma, says KPMG report
- BMS outsources all new molecule stability testing to WuXi
- Scotland boosts bioincubator space to bolster life science sector
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
